Among thyroid papillary carcinomas (PTC), the follicular variant is the most common and includes encapsulated forms (EFVPTC). Non-invasive EFVPTC have very low risk of tumor recurrence or other adverse events and have been recently proposed to be designated as "Non-invasive follicular thyroid neoplasm with papillary-like nuclear features" or "NIFTP", thus eliminating the term "carcinoma". This proposal is expected to significantly impact the risk of malignancy associated with the diagnostic categories currently used to report thyroid cytology. In this study, we analyzed the FNAB cytology features of 96 histologically proven NIFTP and determine how the main nuclear features of NIFTP correlate between cytologic and histologic samples. Blind review of FNAB cytology from NIFTP nodules yielded the diagnosis of "follicular neoplasm" (Bethesda category IV) in 56% of cases, "suspicious for malignancy" (category V) in 27%, "atypia of undetermined significance/follicular lesion of undetermined significance" (category III) in 15%, and "malignant" (category VI) in 2%. We found good correlation (k=0.62) of nuclear features between histological and cytological specimens. Nuclear features (size, irregularities of contours and chromatin clearing) of NIFTP were significantly different from those of benign nodules, but not from those of invasive EFVPTC. Our data indicate that most of NIFTP nodules yield an indeterminate cytological diagnosis in FNAB cytology and nuclear features found in cytology samples are reproducibly identified in corresponding histology samples. Because of the overlapping nuclear features with invasive EFVPTC, NIFTP cannot be reliably diagnosed preoperatively, but should be listed in differential diagnosis of all indeterminate categories of thyroid cytology.
INTRODUCTION
Cancer of the thyroid gland is the most common endocrine malignant neoplasm, and papillary thyroid carcinoma (PTC) accounts for the vast majority of cases. Generally, PTC has a favorable prognosis, with long-term survival rates in excess of 95% [1] . It is well documented that the substantial increase of the incidence of thyroid cancer is mainly due to early detection of neoplasms with indolent behavior, mainly small cancers (microcarcinomas) or the use of more relaxed histopathologic criteria for the follicular variant of PTC (FVPTC) [2, 3] .
In particular, the encapsulated form of FVPTC (EFVPTC) [4] accounts for 10-20% of all thyroid cancers currently diagnosed in Europe and North America [5, 6] . The pathological diagnosis of this variant is associated with a high degree of inter-observer variability and discordance [7, 8] , because it is mainly based on the detection of nuclear features of PTC, which are frequently less evident than in classical PTC. The correct recognition of this entity is thus very subjective. In addition, EFVPTC is known to have an indolent behavior [5, 9, 10] . Cases with incomplete evidence of papillary type nuclei have been either assigned to the category of PTC, or downgraded to follicular adenoma or a category of well differentiated tumors of uncertain malignant potential (WDT-UMP), as suggested by some European authors [11] [12] [13] [14] .
A recent multi-institutional study examined a large cohort of a well-annotated EFVPTC and established that none of 109 patients with non-invasive EFVPTC followed for 10-26 years developed recurrence or other disease manifestations [3] . Based on this information, the international multidisciplinary group of authors recommended to reclassify these tumors as "noninvasive follicular thyroid tumor with papillary-like nuclear features" (NIFTP). NIFTP is defined by a set of reproducible diagnostic criteria that include nuclear features of the papillary carcinoma, such as nuclear size, nuclear membrane irregularities, as well as chromatin clearing (ground-glass appearance), found in a non-invasive encapsulated follicular-patterned tumor.
Fine needle aspiration biopsy (FNAB) is the most important and reliable diagnostic procedure for pre-operative evaluation of a thyroid nodule. At present, most thyroid FNAB specimens are classified according to the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) which includes six diagnostic categories, each of them corresponding to a different risk of malignancy [15] . Other classification systems are currently in use in Europe, including those proposed by the British Thyroid Society [16] and by the Italian SIAPEC [17] , both of them comprising six diagnostic categories, as well. Several previous reports pointed out the challenges in the cytological diagnosis of the FVPTC due to partially overlapping features with both benign and malignant follicular-patterned lesions [14, 18] .
Although histologic features of NIFTP have been well characterized [3] , how reliably these features can be identified in pre-operative cytology samples remains unknown. Furthermore, it remains to be determined what cytological diagnoses the NIFTP nodules will yield in thyroid FNAB and what will be an impact of reclassification of non-invasive EFVPTC on the risk of malignancy in the categories of the Bethesda system. A recent multicentric study suggested that by excluding noninvasive encapsulated FVPTC, many of which are expected now to be diagnosed as NIFTP, the risk of malignancy will decrease significantly in the three indeterminate cytology categories (Bethesda III through V) [19] . In addition, such reclassification will have a profound impact on patient management, as the lesions classified as NIFTP will not require completion thyroidectomy or postsurgical radioiodine therapy. In this study, we provide a detailed analysis of a large series of NIFTP from three Italian institutions in order to characterize their cytological features and correlate them with histologic outcomes.
MATERIALS AND METHODS
Case selection -Cases of NIFTP were retrospectively collected from six different hospitals of three Italian institutions (Universities of Turin, Bologna and Pisa). Before revision, cyto-histological cases were matched and each slide was anonymized and coded by a pathology staff member not involved in the study. Histological materials filed under the original diagnosis of encapsulated FVPTC, WDT-UMP or follicular adenoma with occasional clear nuclei were examined. Criteria for inclusion were: i) histological diagnosis of NIFTP according to the reported criteria (see below) [3] , and ii) availability of an adequate FNAB biopsy sample performed in the same thyroid nodule. In detail, the diagnostic criteria for NIFTP included the follicular growth pattern, complete encapsulation, no invasion, and papillary cancer type nuclei [3] . tridimensional clusters of follicular cells; (xii) high cellularity. For the first three parameters, the extent to which each parameter was represented was recorded as a percentage. In order to parallel the evaluations performed on the corresponding histologica l cases, a score 0 was assigned if the single parameter was absent or present in <50% of cells and score 1 if the parameter was present in >50% of cells, thus yielding a final sum of the three scores from 0 to 3. In some cases, the percentage of nuclear irregularities could not be reliably assessed due to low cellularity, fixation artifact, poorly-stained or partly obscured follicular cells. In these cases, the cytological score was assessed on the basis of the presence/absence of a single parameter, without considering the 50% cut-off. Statistical analysis -Fisher's exact or Chi-square and Student's t tests, for categorical and continuous variables, respectively, were performed to select the cytological parameters associated to the diagnosis of NIFTP, versus benign and malignant tumors, to compare nuclear scores between the groups, to correlate nuclear score and Bethesda categorization, and to compare CD56 immunoreactivity in different tumor types.. A test of concordance (Cohen's kappa) was used to calculate the agreement between histological and cytological scores. The correlation between the extent of the nuclear changes in cytological and histological samples was made using a two tailed Spearman's test. Statistical significance was set at a level of 0.05. All analyses were conducted using.SPSS statistical package .
RESULTS
Cytological diagnosis of NIFTP nodules in FNA samples -The results of blind review of cytology FNAB from nodules histologically diagnosed as NIFTP, benign nodules, and invasive EFVPTC are summarized in Table 1 . Following the Bethesda System for reporting, most (56%) of NIFTP nodules were diagnosed as "suspicious for a follicular neoplasm" (category IV), followed by "suspicious for malignancy" (category V) (27%), and "atypia of undetermined significance/ follicular lesion of undetermined significance" (category III) (15%). Only 2.1% cases were called "malignant" (category VI). On the contrary, benign follicular adenomas and microfollicular hyperplastic nodules were diagnosed as Bethesda category IV (54%) or category III (46%), while invasive EFVPTC were typically diagnosed as Category IV (62.5%) or Category V (37.5%).
Nuclear score evaluation in histological samples -All 55 NIFTP cases in the initial set had a nuclear score of 2 (21 cases) or 3 (34 cases), while benign nodules were scored 0 or 1 and invasive EFVPTC were scored 2 or 3. The mean percentage of nuclear irregularities was significantly different (Student t-test, P=10 -xx ) between NIFTP and benign follicular lesions for each of the three parameters (92.9% vs 21.3% for nuclear size, 72.4% vs 4.3% for nuclear membrane irregularities and 63.8% vs 6.2% for chromatin clearing). Conversely, the differences between NIFTP and invasive EFVPTC were not statistically significant (the latter having mean percentages of 84.2%, 72.9% and 61.7% for enlarged nuclear size, membrane irregularities, and chromatin clearing, respectively).
Nuclear score evaluation in cytological samples -Among all cytological parameters analyzed, nuclear enlargement, nuclear membrane irregularities, optically clear/ground-glass nuclei and nuclear molding were significantly associated to NIFTP diagnosis, irrespective of being evaluated in smears, cell-blocks or both ( Table 2) . A significantly different mean percentage of nuclear alterations (Student t-test, P=xxx) was found between NIFTP cases and benign follicular lesions for each of the three parameters (63.8% vs 33.5% for nuclear size, 69.6% vs 10.3% for nuclear membrane irregularities and 53.9% vs 10% for chromatin clearing). Conversely, as for histological samples, no significant differences were found in FNAB of NIFTP and invasive EFVPTC ( Table 3 In NIFTP, FNAB samples most frequently had a nuclear score of 2 (22 cases) or 3 (n 19 cases), whereas benign follicular lesions had nuclear score 0 in 23 cases, score 1 in 12 cases, and score 2 in 
DISCUSSION
In this study, we report for the first time the cytological features and diagnoses for tumors that histologically belong to a recently described entity of "Non-invasive follicular tumor with papillary type nuclei" (NIFTP) [3] . The results of our analysis indicate that despite heterogeneous expression of nuclear features of papillary carcinoma in the NIFTP nodules, a significant correlation of nuclear features is present between histological and cytological samples in the majority of case. Overall, the most common cytologic diagnosis rendered in FNAB of histologically proven NIFTP nodules is "follicular neoplasm" (Bethesda IV). However, a number of cases had sufficiently evident nuclear features to suggest a diagnosis of suspected malignancy, while in single cases the diagnosis of a papillary carcinoma could be rendered.
In histological specimens, NIFTP is defined as a non-invasive, encapsulated follicular-patterned tumor with cytological features of papillary carcinoma. According to the initial description, the presence of papillary carcinoma type nuclei in NIFTP is heterogeneous in terms of both qualitative and quantitative changes. A nuclear score offered for diagnosing these tumors in the resected specimens is based on the identification of enlarged nuclei, irregular nuclear borders and chromatin clearing [3] . Assigning a value of 1 to each detected parameter, a NIFTP diagnosis requires at least two of the three above features, thus determining a score of 2 or 3. In this study, we find that these features, either all of the three or at least chromatin clearing and irregular borders, can be recognized in FNAB cytology samples, provided that sufficient cellularity is obtained in either smears or cell-blocks or both. More unpredictable is the recognition of such parameters in the NIFTP cases that have focal or only occasional papillary-type nuclei. In those case, the cytological diagnosis Bethesda IV or even III is frequently given.
We found a good correlation between nuclear scores detected in surgical specimens and those in FNAB cytology material. Among specific features, nuclear membrane irregularities had the best correlation. In FNAB cytology specimens, irrespective of being smears or cell-blocks available, the tumor cell size was the least well performing feature, perhaps due to the difficulty of reliably scoring nuclear size in cytology. Of interest, classical features of papillary carcinoma, such as nuclear vacuoles and grooves, were not invariably present in NIFTP. In addition, in some cases of NIFTP, papillary carcinoma-type nuclear features may not be well evident and the co-existence of cell clusters containing follicular cells with dark slightly enlarged nuclei with smooth border prevents the cytologic diagnosis of suspicious for malignancy, and instead prompts diagnosing these samples as "Follicular neoplasm"/Bethesda IV.
Overall, among the three groups of follicular-patterned lesions with known surgical pathology diagnosis studied in this series, most were diagnosed in FNAB samples as either "follicular neoplasm or suspicious for follicular neoplasm" or "atypia of undetermined significance/follicular lesion of undetermined significance" according to the Bethesda system. One of these two cytologic diagnoses was rendered in 100% of benign follicular adenomas/microfollicular goiter nodules, in 63% of invasive EFVPTC, and in 71% of NIFTP cases. However, about one-fourth of NIFTP were interpreted as "suspicious for malignancy" and two tumors as malignant. When compared with the resected specimen, the two cases diagnosed by cytology as malignant had complete encapsulation with no invasion and a follicular architecture with cells having large, markedly irregular nuclei, diffuse clearing of chromatin and scattered nuclear pseudoinclusions and grooves. The existence of such cases raises a possibility that in a cytological sample that lacks evidence of papillary architecture, the finding of even fully developed PTC nuclei cannot exclude the possibility of NIFTP diagnosis after surgery. Since this new terminology is expected to replace a significant proportion of cases previously classified as EFVPTC, this clinical scenario may be relatively common. In a recent study, the impact of reclassifying non-invasive encapsulated follicular variant papillary carcinomas, now designated as NIFTP, on the risk of cancer predicted by FNAB cytology was investigated [19] . It showed that the risk is expected to be reduced in all categories of indeterminate cytology, including atypia of indeterminate significance, follicular neoplasm, and suspicious for malignancy. The current study confirms this expectation directly. As a result, the changes in the reporting of FNAB and predicting the risk of malignancy in these categories of cytology defined by the Bethesda system diagnostic category will be needed.
Importantly, NIFTP appears to have a very indolent behavior, with the risk of recurrence less than 1% in 10 years, as opposed to invasive encapsulated FVPTC that can metastasize and result in patient death [3, 11] . Since the detection of invasion requires surgical excision, this will likely to remain an appropriate therapeutic approach for these tumors. However, in the absence of invasion, it appears that neither completion of thyroidectomy, nor radioiodine treatment is required.
Among additional diagnostic modalities, molecular tests of FNAB material may be useful to distinguish conventional invasive PTC, which more likely to contain BRAF mutations or RET/PTC rearrangements, from pure follicular patterned neoplasms with papillary type nuclei, including invasive EFVPTC and NIFTP, which frequently carry RAS mutations or PAX8-PPARG fusions [3] .
However, whether molecular genotyping can provide high sensitivity and specificity of NIFTP diagnosis in FNAB sample remains to be elucidated. CD56, a neural adhesion molecule expressed in different cells and tumors, including endocrine tumors, was recently proposed as a differential marker to separate follicular tumors from PTC, with the latter being negative [21] . CD56 expression was found to be heterogeneous in this series of NIFTP, with an intermediate profile between follicular and papillary cancers, thus supporting the view that NIFTP shares cytomorphological features with PTC, although CD56 loss was not as complete as reported in conventional PTC [21, 22] .
In conclusion, in this study we observed good correlation of cytological nuclear features between histological and cytological specimens of NIFTP. Moreover, although this tumor cannot be diagnosed with certainty based on FNAB cytology, we showed that nuclear features of NIFTP are significantly different from those of benign follicular tumors and hyperplastic nodules, but not from those of EFVPTC with invasion. Therefore, the presence of papillary carcinoma-type nuclei in a follicular-patterned nodule observed in FNAB cytology should indicate the possibility of not only PTC, but also NIFTP. This could affect the extent of surgery since patients with NIFTP are at very low risk for unfavorable outcome after the nodule excision by hemithyroidectomy. Table 3 . Occurrence of the three most relevant FNAB cytology parameters in NIFTP and other lesions. NOTE. The P-value assesses the differences in the extent of the three parameters between NIFTP and benign follicular lesions (*) and between NIFTP and invasive EFVPTC (**) Table 4 . Correlation between nuclear score and categorization according to the Bethesda System in different tumor types. NOTE. The chi-square test showed significant correlation between nuclear score and Bethesda categorization in the NIFTP category (Chi-square: 32.999, P<0.001) Table 5 . Concordance of scores between FNAB cytology and histology in the whole series of lesions studied. nuclei (less than twice the size of a red blood cell) (A, alcohol-fixed smear stained with H&E; x400), without chromatin clearing (B, alcohol-fixed H&E-stained smear; x400) and with round, regular contours (C, air-dried Giemsa-stained smear; x400). The corresponding histological sample (D, H&E; x400) shows a microfollicular lesion with small, dark and round, regular nuclei, not significantly different from the normal thyroid around the nodule (inset). The second column exemplifies a case of NIFTP with large (E, air-dried smear stained with Giemsa; x400), but dark nuclei (F, alcohol-fixed Pap-stained smear; x400); anyway, irregularities of nuclear contours with grooves could be appreciated (G, alcohol-fixed Pap-stained smear; x400). The corresponding histological sample (H, H&E; x400) shows large and irregular, but prevalently dark nuclei, if compared to normal thyroid (inset). The third column illustrates a case of NIFTP with nuclear score 3 on both cytological (alcohol-fixed Pap-stained smear in I,L and H&E-stained in M; x400) and histological samples (N, H&E; x400). 
